Outcomes of apple oral immunotherapy in pollen food allergy syndrome.

Authors :: Dijkema D
Ruitenbeek MC
Weerstand-Noor K
Oude Elberink HNG
van de Ven AAJM
Source :: The journal of allergy and clinical immunology. Global [J Allergy Clin Immunol Glob] 2024 May 01; Vol. 3 (3), pp. 100271. Date of Electronic Publication: 2024 May 01 (Print Publication: 2024).
Publication Year :: 2024
Abstract: Oral immunotherapy with apple induces tolerance for an entire apple (128 g) in patients with pollen food allergy syndrome who previously tolerated a median amount of 4 g of apple.<br />Competing Interests: Disclosure of potential conflict of interest: H. N. G. Oude Elberink’s institution has received consultancy fees from ALK-Abelló; in addition, she has received fees for delivering lectures from Chiesi, ALK-Abelló, and Meda; consultancy fees from ALK-Abelló; research support from Novartis, MEDA Pharma, Mead Johnson, ALK-Abelló, Shire, and Chiesi; and payment for developing educational presentations from ALK-Abelló. A. A. J. M. van de Ven has received fees for delivering lectures for Takeda. The rest of the authors declare that they have no relevant conflicts of interest.<br /> (© 2024 The Author(s).)